Syngene International to Host Q1 FY27 Earnings Call on July 30 at 9 AM IST

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

Syngene International Limited has scheduled its Q1 FY27 earnings conference call for July 30, 2026, from 9:00 AM to 10:00 AM IST, to discuss financial results for the quarter ended June 2026. The call will feature management discussion and a Q&A session, with dial-in access available across multiple geographies including the US, UK, Singapore, Hong Kong, and Australia. An audio replay will be accessible until August 5, 2026, with recordings and transcripts to be published on the corporate website within seven working days.

powered bylight_fuzz_icon
46278044

*this image is generated using AI for illustrative purposes only.

Syngene International Limited will host a conference call on July 30, 2026, to discuss its financial results for the quarter ended June 2026. The earnings call, scheduled from 9:00 AM to 10:00 AM IST, will provide analysts and investors with an overview of the company's performance in Q1 FY2027. The session will begin with a brief management discussion followed by an interactive Question & Answer session. Participants can join the discussion via dial-in numbers or a webcast link, and a pre-registration facility has been provided to streamline the connection process for attendees.

Conference Call Details

The following dial-in numbers and access details have been made available for participants across geographies:

Feature: Details
Date: Thursday, July 30, 2026
Time: 9:00 AM to 10:00 AM IST
Primary Number: +91 22 6280 1279 / +91 22 7115 8180
USA Number: 18667462133
UK Number: 08081011573
Singapore Number: 8001012045
Hong Kong Number: 800964448
Australia Number: 0080014243444

Access and Replay Options

Participants can join the webcast directly via the provided link. For those unable to attend the live session, a replay facility will be available. The audio replay can be accessed by dialing +91 22 71945757 and using Playback ID 48209#. This facility will be accessible from July 30, 2026, until August 5, 2026. Additionally, the audio recording and a transcript of the conference call will be made available on the corporate website within seven working days of the event.

Syngene International Ltd. is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, and specialty chemical sectors. The company operates over 3 million sq. ft of specialized facilities across India and the U.S.

Historical Stock Returns for Syngene International

1 Day5 Days1 Month6 Months1 Year5 Years
+1.97%+0.84%-0.06%-7.02%-39.13%-31.66%

What key performance indicators should investors focus on during the Q1 FY2027 earnings call?

How might Syngene's recent expansion in the U.S. impact its revenue growth in the upcoming quarters?

What are the expected market trends in the pharmaceutical and biotechnology sectors that could influence Syngene's performance?

like18
dislike

Syngene International accepts General Counsel resignation

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

Syngene International has accepted the resignation of Surender Sharma as General Counsel and Executive Committee member, effective July 15, 2026. The resignation follows a mutual decision as Sharma pursues other career opportunities. The disclosure was made under SEBI LODR regulations.

powered bylight_fuzz_icon
45583045

*this image is generated using AI for illustrative purposes only.

Syngene International has accepted the resignation of Surender Sharma as General Counsel and a member of its Executive Committee. The resignation is effective from the close of business hours on July 15, 2026, following a mutual decision between the executive and the company. Sharma is departing to pursue other career opportunities, marking a change in the company's senior management personnel structure.

The disclosure was made to the stock exchanges pursuant to Regulation 30 read with Para A (7) of Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that the departure is by mutual consent and that all necessary procedural details have been submitted to the exchanges.

The table below summarizes the key details regarding the change in senior management personnel:

S. No. Particulars Details
1. Reason for change Leaving by mutual consent to pursue other career opportunities
2. Date of cessation Effective from close of business hours on July 15, 2026
3. Brief profile Not Applicable
4. Disclosure of relationships Not Applicable

Chethan Yogesh, Company Secretary & Compliance Officer of Syngene International, signed the regulatory filing on July 14, 2026. The information regarding this change in senior management has been made available on the company's official website.

Historical Stock Returns for Syngene International

1 Day5 Days1 Month6 Months1 Year5 Years
+1.97%+0.84%-0.06%-7.02%-39.13%-31.66%

Who will be appointed as the new General Counsel to fill the vacancy left by Surender Sharma?

How will this leadership change impact Syngene International's ongoing legal and compliance strategies?

What are the potential market reactions to this senior management transition?

like17
dislike

More News on Syngene International

1 Year Returns:-39.13%